The Pathogenesis of Advanced Cervical Cancer Provides the Basis for an Empirical Therapeutic Vaccine

This publication has 30 references indexed in Scilit:

• Tumour-induced suppression of immune response and its correction
  Cancer Immunology, Immunotherapy, 2001
• Recurrent Respiratory Papillomatosis: Altered CD8+ T-Cell Subsets and TH1/TH2 Cytokine Imbalance
  Clinical Immunology, 1999
• Downregulation of T helper type 1 immune response and altered pro-inflammatory and anti-inflammatory T cell cytokine balance following conventional but not laparoscopic surgery
  The American Journal of Surgery, 1999
• Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma
  Surgery, 1996
• Immunologic Diagnosis and Monitoring of Cervical Cancers Using in Vitro Translated HPV Proteins
  Gynecologic Oncology, 1995
• Antibodies to human papillomavirus type 16 E7 related to clinicopathological data in patients with cervical carcinoma.
  Journal of Clinical Pathology, 1995
• Differences in MHC and TAP-1 expression in cervical cancer lymph node metastases as compared with the primary tumours
  British Journal of Cancer, 1994
• Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical carcinomas.
  The Journal of Experimental Medicine, 1994
• Loss of MHC class‐I expression in cervical carcinomas
  International Journal of Cancer, 1990
• Antigen presentation by keratinocytes induces tolerance in human T cells
  European Journal of Immunology, 1990